Importantly, patients with severe COVID-19 show loss-of-function variants in Toll-like receptor (TLR)- and IFN-dependent genes, or neutralizing antibodies to type I IFN (α and ω; Bastard et al., 2020; Zhang et al., 2020a). Here, IFNA1 is linked to COVID-19.